EarlyDx Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 8

EarlyDx General Information

Description

Developer of a diagnostic and bioinformatics platform designed for early disease detection and health monitoring purposes. The company's platform integrates sequencing technology and computational methods to analyze genome-wide methylation profiles of cell-free DNA from a single blood sample, features an ultrasensitive library preparation technique, and provides cloud-based bioinformatics tools for data analysis, enabling healthcare providers and diagnostic companies to access affordable, non-invasive, and comprehensive solutions for cancer detection, therapy selection, and treatment monitoring.

Contact Information

Website
www.earlydx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 30601 Agoura Road
  • Suite 250, Agoura Hills
  • Los Angeles, CA 91301
  • United States
+1 (310)
Primary Industry
Diagnostic Equipment
Corporate Office
  • 30601 Agoura Road
  • Suite 250, Agoura Hills
  • Los Angeles, CA 91301
  • United States
+1 (310)

EarlyDx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EarlyDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 01-Jun-2025 Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
8. Later Stage VC (Series A) 29-Sep-2022 Cancelled Generating Revenue
7. Seed Round 01-Dec-2022 Completed Generating Revenue
6. Grant 29-Sep-2022 Completed Generating Revenue
5. Grant 01-Jun-2020 Completed Generating Revenue
4. Seed Round 20-Feb-2020 Completed Generating Revenue
3. Seed Round 31-Jan-2018 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2014 Completed Startup
To view EarlyDx’s complete valuation and funding history, request access »

EarlyDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
Seed 3,200,000 $0.000100 $1.9 $1.9 1x $1.9 14.34%
To view EarlyDx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

EarlyDx Patents

EarlyDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026222157-A1 Methods for monitoring transplant outcomes Pending 16-Apr-2025
EP-4655070-A1 Methods of hyper- and hypo-methylation analysis for disease detection Pending 27-Jan-2023
US-20260226553-A1 Methods of hyper- and hypo-methylation analysis for disease detection Pending 27-Jan-2023
WO-2024159118-A1 Methods of hyper- and hypo-methylation analysis for disease detection Inactive 27-Jan-2023
US-20250092446-A1 Methods of methylation analysis for disease detection Pending 07-Jul-2021 C12Q1/683
To view EarlyDx’s complete patent history, request access »

EarlyDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EarlyDx Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Device of Tomorrow Capital Venture Capital Minority
Magnify Accelerator/Incubator
Westfield BioVentures Accelerator/Incubator Minority
National Cancer Institute Government
National Institutes of Health Government Minority
You’re viewing 5 of 8 investors. Get the full list »

EarlyDx FAQs

  • When was EarlyDx founded?

    EarlyDx was founded in 2014.

  • Where is EarlyDx headquartered?

    EarlyDx is headquartered in Los Angeles, CA.

  • What is the size of EarlyDx?

    EarlyDx has 8 total employees.

  • What industry is EarlyDx in?

    EarlyDx’s primary industry is Diagnostic Equipment.

  • Is EarlyDx a private or public company?

    EarlyDx is a Private company.

  • What is EarlyDx’s current revenue?

    The current revenue for EarlyDx is .

  • How much funding has EarlyDx raised over time?

    EarlyDx has raised $14M.

  • Who are EarlyDx’s investors?

    Device of Tomorrow Capital, Magnify, Westfield BioVentures, National Cancer Institute, and National Institutes of Health are 5 of 8 investors who have invested in EarlyDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process